![Efficacy and safety of GV1001 in patients with moderate-to-severe Alzheimer's disease already receiving donepezil: a phase 2 randomized, double-blind, placebo-controlled, multicenter clinical trial | Alzheimer's Research & Therapy | Full Text Efficacy and safety of GV1001 in patients with moderate-to-severe Alzheimer's disease already receiving donepezil: a phase 2 randomized, double-blind, placebo-controlled, multicenter clinical trial | Alzheimer's Research & Therapy | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13195-021-00803-w/MediaObjects/13195_2021_803_Fig2_HTML.png)
Efficacy and safety of GV1001 in patients with moderate-to-severe Alzheimer's disease already receiving donepezil: a phase 2 randomized, double-blind, placebo-controlled, multicenter clinical trial | Alzheimer's Research & Therapy | Full Text
PLOS ONE: The Effect of Daily Self-Measurement of Pressure Pain Sensitivity Followed by Acupressure on Depression and Quality of Life versus Treatment as Usual in Ischemic Heart Disease: A Randomized Clinical Trial
![Frontiers | Design, Conduct, and Use of Patient Preference Studies in the Medical Product Life Cycle: A Multi-Method Study | Pharmacology Frontiers | Design, Conduct, and Use of Patient Preference Studies in the Medical Product Life Cycle: A Multi-Method Study | Pharmacology](https://www.frontiersin.org/files/Articles/490751/fphar-10-01395-HTML-r2/image_m/fphar-10-01395-g002.jpg)
Frontiers | Design, Conduct, and Use of Patient Preference Studies in the Medical Product Life Cycle: A Multi-Method Study | Pharmacology
![Efficacy and Tolerability of Combination Therapy Versus Monotherapy with Candesartan and/or Amlodipine for Dose Finding in Essential Hypertension: A Phase II Multicenter, Randomized, Double-blind Clinical Trial - Clinical Therapeutics Efficacy and Tolerability of Combination Therapy Versus Monotherapy with Candesartan and/or Amlodipine for Dose Finding in Essential Hypertension: A Phase II Multicenter, Randomized, Double-blind Clinical Trial - Clinical Therapeutics](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2119327225/2092243685/gr1.jpg)
Efficacy and Tolerability of Combination Therapy Versus Monotherapy with Candesartan and/or Amlodipine for Dose Finding in Essential Hypertension: A Phase II Multicenter, Randomized, Double-blind Clinical Trial - Clinical Therapeutics
![A randomized, double-blind, multicenter Phase II study comparing the efficacy and safety of oral nemonoxacin with oral levofloxacin in the treatment of community-acquired pneumonia - ScienceDirect A randomized, double-blind, multicenter Phase II study comparing the efficacy and safety of oral nemonoxacin with oral levofloxacin in the treatment of community-acquired pneumonia - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1684118215009159-gr1.jpg)
A randomized, double-blind, multicenter Phase II study comparing the efficacy and safety of oral nemonoxacin with oral levofloxacin in the treatment of community-acquired pneumonia - ScienceDirect
Paradigm Biopharmaceuticals Ltd receives ethics approval for Phase 2 clinical trial of PPS in knee osteoarthritis pain
![Flow diagram for the clinical trial. PPS, per-protocol set; FAS, full... | Download Scientific Diagram Flow diagram for the clinical trial. PPS, per-protocol set; FAS, full... | Download Scientific Diagram](https://www.researchgate.net/publication/360000464/figure/fig1/AS:1146028258541568@1650245837142/Flow-diagram-for-the-clinical-trial-PPS-per-protocol-set-FAS-full-analysis-set_Q640.jpg)
Flow diagram for the clinical trial. PPS, per-protocol set; FAS, full... | Download Scientific Diagram
![Non-inferiority of mammalian cell-derived quadrivalent subunit influenza virus vaccines compared to trivalent subunit influenza virus vaccines in healthy children: a phase III randomized, multicenter, double-blind clinical trial - International Journal ... Non-inferiority of mammalian cell-derived quadrivalent subunit influenza virus vaccines compared to trivalent subunit influenza virus vaccines in healthy children: a phase III randomized, multicenter, double-blind clinical trial - International Journal ...](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2041261395/2055102524/gr1.gif)
Non-inferiority of mammalian cell-derived quadrivalent subunit influenza virus vaccines compared to trivalent subunit influenza virus vaccines in healthy children: a phase III randomized, multicenter, double-blind clinical trial - International Journal ...
![Efficacy, safety and immunogenicity of live attenuated varicella vaccine in healthy children in China: double-blind, randomized, placebo-controlled clinical trial - Clinical Microbiology and Infection Efficacy, safety and immunogenicity of live attenuated varicella vaccine in healthy children in China: double-blind, randomized, placebo-controlled clinical trial - Clinical Microbiology and Infection](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/940badd5-adc7-42ba-8d29-2e2c7196604e/gr1.jpg)
Efficacy, safety and immunogenicity of live attenuated varicella vaccine in healthy children in China: double-blind, randomized, placebo-controlled clinical trial - Clinical Microbiology and Infection
![Reproductive outcomes and reproductive tract microbiota shift in women with moderate-to-severe intrauterine adhesions following 30-day post-hysteroscopic placement of balloon stents or intrauterine contraceptive devices: A randomized controlled trial ... Reproductive outcomes and reproductive tract microbiota shift in women with moderate-to-severe intrauterine adhesions following 30-day post-hysteroscopic placement of balloon stents or intrauterine contraceptive devices: A randomized controlled trial ...](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/b9261aae-620b-444b-bdcc-789aeb3ab292/gr1_lrg.jpg)
Reproductive outcomes and reproductive tract microbiota shift in women with moderate-to-severe intrauterine adhesions following 30-day post-hysteroscopic placement of balloon stents or intrauterine contraceptive devices: A randomized controlled trial ...
![Paradigm's (ASX:PAR) PPS as a potential breakthrough in the treatment of viral arthritis and joint pain - Techboard Paradigm's (ASX:PAR) PPS as a potential breakthrough in the treatment of viral arthritis and joint pain - Techboard](https://i0.wp.com/techboard.com.au/wp-content/uploads/2016/09/Courier-Mail-clip.png?fit=1004%2C931&ssl=1)
Paradigm's (ASX:PAR) PPS as a potential breakthrough in the treatment of viral arthritis and joint pain - Techboard
![Overall survival and post-progression survival are potent endpoint in phase III trials of second/third-line chemotherapy for advanced or recurrent epithelial ovarian cancer Overall survival and post-progression survival are potent endpoint in phase III trials of second/third-line chemotherapy for advanced or recurrent epithelial ovarian cancer](https://www.jcancer.org/v09/p0872/jcav09p0872g001.jpg)
Overall survival and post-progression survival are potent endpoint in phase III trials of second/third-line chemotherapy for advanced or recurrent epithelial ovarian cancer
![Comprehensive rehabilitation with integrative medicine for subacute stroke: A multicenter randomized controlled trial | Scientific Reports Comprehensive rehabilitation with integrative medicine for subacute stroke: A multicenter randomized controlled trial | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fsrep25850/MediaObjects/41598_2016_Article_BFsrep25850_Fig1_HTML.jpg)
Comprehensive rehabilitation with integrative medicine for subacute stroke: A multicenter randomized controlled trial | Scientific Reports
![Efficacy and Tolerability of Pitavastatin Versus Pitavastatin/Fenofibrate in High-risk Korean Patients with Mixed Dyslipidemia: A Multicenter, Randomized, Double-blinded, Parallel, Therapeutic Confirmatory Clinical Trial - Clinical Therapeutics Efficacy and Tolerability of Pitavastatin Versus Pitavastatin/Fenofibrate in High-risk Korean Patients with Mixed Dyslipidemia: A Multicenter, Randomized, Double-blinded, Parallel, Therapeutic Confirmatory Clinical Trial - Clinical Therapeutics](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/f7295455-24fb-4137-a491-073cae0e8d32/gr1_lrg.jpg)
Efficacy and Tolerability of Pitavastatin Versus Pitavastatin/Fenofibrate in High-risk Korean Patients with Mixed Dyslipidemia: A Multicenter, Randomized, Double-blinded, Parallel, Therapeutic Confirmatory Clinical Trial - Clinical Therapeutics
![Phase 3, Randomized, Double-Blind, Active-Comparator (Darbepoetin Alfa) Study of Oral Roxadustat in CKD Patients with Anemia on Hemodialysis in Japan | American Society of Nephrology Phase 3, Randomized, Double-Blind, Active-Comparator (Darbepoetin Alfa) Study of Oral Roxadustat in CKD Patients with Anemia on Hemodialysis in Japan | American Society of Nephrology](https://jasn.asnjournals.org/content/31/7/1628/F1.large.jpg)
Phase 3, Randomized, Double-Blind, Active-Comparator (Darbepoetin Alfa) Study of Oral Roxadustat in CKD Patients with Anemia on Hemodialysis in Japan | American Society of Nephrology
Paradigm Biopharmaceutical Ltd's PPS heart failure treatment generates promising data from pre-clinical animal model trial
![Human cerebral organoids as a therapeutic drug screening model for Creutzfeldt–Jakob disease | Scientific Reports Human cerebral organoids as a therapeutic drug screening model for Creutzfeldt–Jakob disease | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-021-84689-6/MediaObjects/41598_2021_84689_Fig1_HTML.png)